Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system

被引:18
作者
de Queiroz, Nina Mari G. P. [1 ]
Marinho, Fabio V. [1 ]
Chagas, Marcelo A. [1 ]
Leite, Luciana C. C. [2 ]
Homan, E. Jane [3 ]
de Magalhaes, Mariana T. Q. [1 ]
Oliveira, Sergio C. [1 ,4 ]
机构
[1] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil
[2] Inst Butantan, Lab Desenvolvimento Vacinas, Sao Paulo, SP, Brazil
[3] ioGenetics LLC, Madison, WI USA
[4] CNPq MCT, Inst Nacl Ciencia & Tecnol Doencas Trop INCT DT, Salvador, BA, Brazil
基金
巴西圣保罗研究基金会; 美国国家卫生研究院;
关键词
COVID-19; SARS-CoV-2; RBD domain; Vaccines; BCG; ACUTE RESPIRATORY SYNDROME; T-CELL RESPONSES; HUMAN MONOCLONAL-ANTIBODIES; ADAPTIVE IMMUNE-RESPONSES; SARS-CORONAVIRUS; CALMETTE-GUERIN; FUNCTIONAL RECEPTOR; TRAINED IMMUNITY; EBOLA VACCINE; PROTECTS MICE;
D O I
10.1016/j.micinf.2020.09.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This article discusses standard and new disruptive strategies in the race to develop an anti-COVID-19 vaccine. We also included new bioinformatic data from our group mapping immunodominant epitopes and structural analysis of the spike protein. Another innovative approach reviewed here is the use of BCG vaccine as priming strategy and/or delivery system expressing SARS-CoV-2 antigens. (C) 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:515 / 524
页数:10
相关论文
共 142 条
  • [1] Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
    Ahmed, Syed Faraz
    Quadeer, Ahmed A.
    McKay, Matthew R.
    [J]. VIRUSES-BASEL, 2020, 12 (03):
  • [2] HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES TO LIVE RECOMBINANT BCG-HIV VACCINES
    ALDOVINI, A
    YOUNG, RA
    [J]. NATURE, 1991, 351 (6326) : 479 - 482
  • [3] Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity
    Ami, Y
    Izumi, Y
    Matsuo, K
    Someya, K
    Kanekiyo, M
    Horibata, S
    Yoshino, N
    Sakai, K
    Shinohara, K
    Matsumoto, S
    Yamada, T
    Yamazaki, S
    Yamamoto, N
    Honda, M
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (20) : 12871 - 12879
  • [4] The proximal origin of SARS-CoV-2
    Andersen, Kristian G.
    Rambaut, Andrew
    Lipkin, W. Ian
    Holmes, Edward C.
    Garry, Robert F.
    [J]. NATURE MEDICINE, 2020, 26 (04) : 450 - 452
  • [5] BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
    Arts, Rob J. W.
    Moorlag, Simone J. C. F. M.
    Novakovic, Boris
    Li, Yang
    Wang, Shuang-Yin
    Oosting, Marije
    Kumar, Vinod
    Xavier, Ramnik J.
    Wijmenga, Cisca
    Joosten, Leo A. B.
    Reusken, Chantal B. E. M.
    Benn, Christine S.
    Aaby, Peter
    Koopmans, Marion P.
    Stunnenberg, Hendrik G.
    van Crevel, Reinout
    Netea, Mihai G.
    [J]. CELL HOST & MICROBE, 2018, 23 (01) : 89 - +
  • [6] Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
    Belouzard, Sandrine
    Millet, Jean K.
    Licitra, Beth N.
    Whittaker, Gary R.
    [J]. VIRUSES-BASEL, 2012, 4 (06): : 1011 - 1033
  • [7] Architecture of the SARS coronavirus prefusion spike
    Beniac, Daniel R.
    Andonov, Anton
    Grudeski, Elsie
    Booth, Tim F.
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (08) : 751 - 752
  • [8] Mandated Bacillus Calmette-Guerin (BCG) vaccination predicts flattened curves for the spread of COVID-19
    Berg, Martha K.
    Yu, Qinggang
    Salvador, Cristina E.
    Melani, Irene
    Kitayama, Shinobu
    [J]. SCIENCE ADVANCES, 2020, 6 (32)
  • [9] BLOOM BR, 1989, ANN NY ACAD SCI, V569, P155, DOI 10.1111/j.1749-6632.1989.tb27366.x
  • [10] In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation
    Bouvet, Mickael
    Debarnot, Claire
    Imbert, Isabelle
    Selisko, Barbara
    Snijder, Eric J.
    Canard, Bruno
    Decroly, Etienne
    [J]. PLOS PATHOGENS, 2010, 6 (04) : 1 - 13